Pharma Cinq, LLC
2Patents
2Active
2Granted
42Portfolio score
Filing activity: Feb 10, 2021 → Feb 16, 2021
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US12076367B2 | Fusion protein between short form rod-derived cone viability factor and a hydrophilic peptide | Chemistry; Metallurgy | 0 | Active |
| US12139483B2 | Imidazoquinolyl compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activity | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.